| 2025-08-12 |
复牌提示：
2025-08-11 19:50:00 停牌，复牌日期 2025-08-13 00:00:01
|
| 2025-07-18 |
详情>>
内部人交易：
Green Wyche T III股份减少7008.00股
|
| 2025-07-10 |
股东大会：
将于2025-08-07召开股东大会
会议内容 ▼▲
- 1.To adopt the Agreement and Plan of Merger, dated as of May 29, 2025 (as it may be amended from time to time, the “Merger Agreement”), by and among Streamline, Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit (“Parent” and, together with its affiliates, “MDaudit”), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, and upon the terms and subject to the conditions set forth therein, Merger Sub will be merged with and into Streamline, with Streamline continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (such merger, the “Merger” and such proposal, the “Merger Proposal”).
2.To approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Streamline’s named executive officers in connection with the Merger (the “Compensation Proposal”).
3.To approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes present or represented by proxy at the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”).
|
| 2025-06-16 |
详情>>
股本变动：
变动后总股本435.61万股
|
| 2025-06-16 |
详情>>
业绩披露：
2026年一季报每股收益-0.4美元,归母净利润-164.5万美元,同比去年增长39.94%
|
| 2025-05-02 |
详情>>
业绩披露：
2025年年报每股收益-2.53美元,归母净利润-1015.9万美元,同比去年增长45.67%
|
| 2024-12-20 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.01美元,归母净利润-801.8万美元,同比去年增长53.73%
|
| 2024-09-26 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2024-09-12 |
详情>>
业绩披露：
2025年中报每股收益-0.09美元,归母净利润-554.2万美元,同比去年增长-2.33%
|
| 2024-09-11 |
财报披露：
美东时间 2024-09-11 盘后发布财报
|
| 2024-08-19 |
股东大会：
将于2024-09-19召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the Company’s Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio of any whole number between 1-for-5 and 1-for-15, at any time prior to October 4, 2024, with the exact ratio to be set within that range at the discretion of the Board, without further approval or authorization of the Company’s stockholders;
2.To approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt Proposal 1. Consideration of any other business properly brought before the Special Meeting or any adjournments thereof.
|
| 2024-06-12 |
详情>>
业绩披露：
2025年一季报每股收益-0.05美元,归母净利润-273.9万美元,同比去年增长5.58%
|
| 2024-05-13 |
股东大会：
将于2024-06-13召开股东大会
会议内容 ▼▲
- 1.To elect the seven candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2025 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers.
3.To ratify the appointment of the firm of FORVIS, LLP to serve as our independent registered public accounting firm for fiscal year 2024.
4.To approve the Streamline Health Solutions, Inc. 2024 Omnibus Incentive Compensation Plan (the “2024 Plan”).
5.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2024-04-30 |
详情>>
业绩披露：
2024年年报每股收益-0.33美元,归母净利润-1869.7万美元,同比去年增长-64.31%
|
| 2023-12-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.31美元,归母净利润-1732.7万美元,同比去年增长-88.4%
|
| 2023-09-14 |
详情>>
业绩披露：
2024年中报每股收益-0.1美元,归母净利润-541.6万美元,同比去年增长10.61%
|
| 2023-06-14 |
详情>>
业绩披露：
2024年一季报每股收益-0.05美元,归母净利润-290.1万美元,同比去年增长-4.09%
|
| 2023-05-11 |
股东大会：
将于2023-06-15召开股东大会
会议内容 ▼▲
- 1.To elect the five candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2024 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers (“say-on-pay”).
3.To ratify the appointment of the firm of FORVIS, LLP (hereafter referred to as “FORVIS”) to serve as our independent registered public accounting firm for fiscal year 2023.
4.To approve an amendment to Streamline Health Solutions, Inc.’s Third Amended and Restated 2013 Stock Incentive Plan (the “Third Amended 2013 Plan”), to increase the number of shares of common stock available for issuance under the Third Amended 2013 Plan.
5.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2023-04-27 |
详情>>
业绩披露：
2023年年报每股收益-0.23美元,归母净利润-1137.9万美元,同比去年增长-73.94%
|
| 2022-05-09 |
股东大会：
将于2022-06-07召开股东大会
会议内容 ▼▲
- 1.To elect the five candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2023 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers (“say-on-pay”).
3.To ratify the appointment of the firm of Dixon Hughes Goodman LLP to serve as our independent registered public accounting firm for fiscal year 2022.
4.To approve an amendment to the company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to increase the total number of authorized shares of common stock from 65,000,000 shares to 85,000,000 shares.
5.To approve an amendment to Streamline Health Solutions, Inc.’s Third Amended and Restated 2013 Stock Incentive Plan (the “Plan”), to increase the number of shares of common stock available for issuance under the Plan.
6.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-06 |
股东大会：
将于2021-07-29召开股东大会
会议内容 ▼▲
- 1.To ratify the approval, filing and effectiveness of the Certificate of Amendment to our Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on May 24, 2021 (the “May 2021 Charter Amendment”), and the increase in the total number of authorized shares of common stock from 45,000,000 shares to 65,000,000 shares (the “Authorized Shares Increase”), which became effective on May 24, 2021 (the “Charter Amendment Ratification”).
2.To ratify the approval and effectiveness of an amendment to our Third Amended and Restated 2013 Stock Incentive Plan (the “Third Amended 2013 Plan”) increasing the number of authorized shares available for issuance under the Third Amended 2013 Plan (the “Third Amended 2013 Plan Amendment”), which was filed with the U.S. Securities and Exchange Commission on May 24, 2021 and became effective as of the same date (the “Plan Amendment Ratification” and together with the Charter Amendment Ratification, the “Ratifications”). The Plan Amendment Ratification is conditioned upon the Charter Amendment Ratification.
3.To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Ratifications (the “Adjournment Proposal”).
4.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2021-04-22 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the five candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2022 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve, on a non-binding advisory basis, the compensation of our named executive officers (“say-on-pay”).
3.To approve, on a non-binding advisory basis, the option for the frequency of future advisory votes on executive compensation (“say-on-pay frequency”).
4.To ratify the appointment of the firm of Dixon Hughes Goodman LLP to serve as our independent registered public accounting firm for fiscal year 2021.
5.To approve an amendment to our Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to increase the total number of authorized shares of common stock from 45,000,000 shares to 65,000,000 shares.
6.To approve an amendment to the Certificate of Incorporation to remove the 66 2/3% supermajority voting requirements in the Certificate of Incorporation.
7.To approve an amendment to our Third Amended and Restated 2013 Stock Incentive Plan (the “Third Amended 2013 Plan”), which would increase the number of authorized shares available for issuance under the Third Amended 2013 Plan, conditioned upon the approval of Proposal 5.
8.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2020-04-22 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the five candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2021 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve a non-binding advisory vote on the compensation of our named executive officers (“say-on-pay”).
3.To ratify the appointment of the firm of Dixon Hughes Goodman LLP to serve as our independent registered public accounting firm for fiscal year 2020.
4.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2019-04-22 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.To elect the five candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2020 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve a non-binding advisory vote on the compensation of our named executive officers (“say-on-pay”).
3.To approve, on a non-binding advisory basis, the option of every one year for the frequency of future advisory votes on executive compensation (“say-on-pay frequency”).
4.To approve the Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan.
5.To ratify the appointment of the firm of Dixon Hughes Goodman LLP to serve as our independent registered public accounting firm for fiscal year 2019.
6. To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2018-12-28 |
股东大会：
将于2019-01-29召开股东大会
会议内容 ▼▲
- 1.To elect the six candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2018 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve a non-binding advisory vote on the compensation of our named executive officers ("say-on-pay").
3.To ratify the appointment of the firm of RSM US LLP to serve as our independent registered public accounting firm for fiscal year 2018.
4.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2017-05-02 |
股东大会：
将于2017-06-01召开股东大会
会议内容 ▼▲
- 1.To elect the six candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2018 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve a non-binding advisory vote on the compensation of our named executive officers ("say-on-pay").
3.To approve the Streamline Health Solutions, Inc. Second Amended and Restated 2013 Stock Incentive Plan.
4.To ratify the appointment of the firm of RSM US LLP to serve as our independent registered public accounting firm for fiscal year 2017.
5.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|
| 2016-05-02 |
股东大会：
将于2016-05-25召开股东大会
会议内容 ▼▲
- 1.To elect the six candidates nominated by our board of directors to serve as directors until a successor is duly elected and qualified at the 2017 Annual Meeting of Stockholders or otherwise or until any earlier removal or resignation.
2.To approve a non-binding advisory vote on the compensation of our named executive officers ("say-on-pay").
3.To ratify the appointment of the firm of RSM US LLP to serve as our independent registered public accounting firm for fiscal year 2016.
4.To consider any and all other business that may properly come before the meeting or any adjournment thereof.
|